Emergent Biosolutions EBS Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Emergent Biosolutions's other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Emergent Biosolutions's other income (expense)?
- Emergent Biosolutions (EBS) reported other income (expense) of $2.9M in Q1 2026.
- How has Emergent Biosolutions's other income (expense) changed year-over-year?
- Emergent Biosolutions's other income (expense) decreased by 93.2% year-over-year, from $42.8M to $2.9M.
- What is the long-term trend for Emergent Biosolutions's other income (expense)?
- Over 4 years (2021 to 2025), Emergent Biosolutions's other income (expense) has grown at a -18.0% compound annual growth rate (CAGR), from -$38.2M to -$17.3M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.